ModivCare Inc.
MODV · NASDAQ Global Select · USD
0,4319USD
0,00 (0,00 %)Stand 4. Sept., 20:00
Kennzahlen
- Eröffnung
- 0,4319
- Vortag
- 0,4319
- Tagesspanne
- 0,4319 – 0,4319
- 52 Wochen
- 0,2822 – 32,82
- Ø Volumen
- 8,27 Mio.
- Börsenwert
- 6,2 Mio. $
- KGV
- -0,0
- Gewinn je Aktie (TTM)
- -31,40
- Dividendenrendite
- 0,0 %
- Beta
- 1,3
- Nächste Zahlen
- –
Finanzen
| USD | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Umsatz | 2,79 Mrd. | 2,75 Mrd. | 2,5 Mrd. | 2 Mrd. | 1,37 Mrd. |
| Herstellungskosten | 2,37 Mrd. | 2,3 Mrd. | 2,03 Mrd. | 1,58 Mrd. | 1,08 Mrd. |
| Bruttogewinn | 420,37 Mio. | 446,95 Mio. | 472,32 Mio. | 412,59 Mio. | 289,88 Mio. |
| Forschung und Entwicklung | 0 | 0 | 0 | 0 | 0 |
| Vertrieb und Verwaltung | 298,39 Mio. | 304,56 Mio. | 322,17 Mio. | 271,27 Mio. | 140,54 Mio. |
| Operatives Ergebnis | −92,79 Mio. | −139,95 Mio. | 57,08 Mio. | 89,77 Mio. | 123,16 Mio. |
| EBITDA | 4,88 Mio. | −23,33 Mio. | 157,5 Mio. | 146,36 Mio. | 149,34 Mio. |
| Nettogewinn | −201,28 Mio. | −204,46 Mio. | −1,84 Mio. | 31,96 Mio. | 88,84 Mio. |
| Gewinn je Aktie (verwässert) | -14,14 | -14,43 | -0,13 | 2,27 | 2,37 |
Umsatz nach Segment
Produkte · FY 2024
- Other Service Revenue7,27 Mio. $100,00 %
Anteil · ggü. Vorjahr (FY 2023)
Regionen · FY 2017
- UNITED STATES1,34 Mrd. $92,98 %+20,08 %
- Other Foreign100,84 Mio. $7,02 %
Anteil · ggü. Vorjahr (FY 2013)
Bewertung
Letzte 12 Monate
- KGV
- -0,0
- Kurs-Umsatz-Verhältnis
- 0,0
- Kurs-Buchwert-Verhältnis
- -0,0
- PEG
- 0,0
- Bruttomarge
- 0,0 %
- Operative Marge
- −0,9 %
- Nettomarge
- −28,1 %
- Verschuldungsgrad
- -0,1
- EV/EBITDA
- 0,2
- Eigenkapitalrendite
- 88,1 %
- Kapitalrendite (ROIC)
- −1,1 %
- Free-Cashflow-Rendite
- −2.243,6 %
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | |
|---|---|---|---|---|---|
| Bruttomarge | 15,1 % | 16,2 % | 18,9 % | 20,7 % | 21,2 % |
| Operative Marge | −3,3 % | −5,1 % | 2,3 % | 4,5 % | 9,0 % |
| Nettomarge | −7,2 % | −7,4 % | −0,1 % | 1,6 % | 6,5 % |
| KGV | -0,8 | -3,0 | -690,2 | 65,3 | 58,0 |
| Kurs-Umsatz-Verhältnis | 0,1 | 0,2 | 0,5 | 1,0 | 1,4 |
| Kurs-Buchwert-Verhältnis | -4,4 | 4,0 | 3,6 | 5,6 | 4,6 |
| Verschuldungsgrad | -33,8 | 7,3 | 2,9 | 2,7 | 1,3 |
| Liquidität 3. Grades | 0,8 | 0,8 | 0,7 | 0,8 | 1,3 |
| Dividendenrendite | 0,0 % | 0,0 % | 0,0 % | 0,0 % | 4,8 % |
| Unternehmenswert | 1,36 Mrd. | 1,76 Mrd. | 2,27 Mrd. | 2,97 Mrd. | 2,22 Mrd. |
| EV/EBITDA | 278,3 | -75,5 | 14,4 | 20,3 | 14,8 |
| Eigenkapitalrendite | 523,2 % | −130,9 % | −0,5 % | 8,6 % | 21,6 % |
| Kapitalrendite (ROIC) | −6,9 % | −10,0 % | 1,5 % | 4,7 % | 8,7 % |
| Free-Cashflow-Rendite | −20,2 % | −20,1 % | −3,4 % | 7,9 % | 17,9 % |
Wachstum
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | |
|---|---|---|---|---|---|
| Umsatz | +1,3 % | +9,9 % | +25,4 % | +45,9 % | −9,4 % |
| Bruttogewinn | −5,9 % | −5,4 % | +14,5 % | +42,3 % | +166,5 % |
| Operatives Ergebnis | +33,7 % | −345,2 % | −36,4 % | −27,1 % | +2.733,8 % |
| Nettogewinn | +1,6 % | −10.999,9 % | −105,8 % | −64,0 % | +1.893,6 % |
| Gewinn je Aktie | +2,0 % | −11.000,0 % | −105,7 % | −4,2 % | +723,7 % |
| Freier Cashflow | +72,8 % | −188,3 % | −126,2 % | −50,8 % | +571,5 % |
| Dividende je Aktie | 0,0 % | 0,0 % | 0,0 % | −100,0 % | +1.868,8 % |
Analysten
Einstufungen · Hold
- 0Stark kaufen
- 1Kaufen
- 4Halten
- 0Verkaufen
- 0Stark verkaufen
Kursziel
19,80
Durchschnitt · +4.484,39 %
Schätzungen
| FY 2026 | FY 2027 | |
|---|---|---|
| Umsatz (Ø) | 2,79 Mrd. | 2,81 Mrd. |
| Umsatz (Tief – Hoch) | 2,78 Mrd. – 2,8 Mrd. | 2,81 Mrd. – 2,82 Mrd. |
| Gewinn je Aktie (Ø) | -3,24 | 0,87 |
| Gewinn je Aktie (Tief – Hoch) | -9,46 – 2,98 | 0,87 – 0,87 |
| Analysten | 1 | 1 |
Letzte Änderungen
- Barrington Research12. Mai 2025Outperform → Market Perform
- Stephens & Co.10. März 2025Equal Weight
- Barrington Research7. März 2025Outperform
- Barrington Research14. Jan. 2025Outperform
- Lake Street13. Jan. 2025Buy
- Stephens & Co.10. Jan. 2025Overweight → Equal Weight
- Barrington Research18. Nov. 2024Outperform
- Barrington Research8. Nov. 2024Outperform
Quartalszahlen
| Dez. 2025 | Aug. 2025 | Mai 2025 | März 2025 | Nov. 2024 | Aug. 2024 | Mai 2024 | Feb. 2024 | |
|---|---|---|---|---|---|---|---|---|
| Gewinn je Aktie · Erwartet | -0,91 | -0,51 | -0,34 | -0,10 | 0,59 | 0,81 | 0,20 | 1,22 |
| Gewinn je Aktie · Tatsächlich | -5,08 | -0,14 | -1,71 | 0,19 | 0,45 | -0,03 | -0,09 | 1,29 |
| Abweichung | −458,24 % | +72,55 % | −402,94 % | +290,00 % | −23,73 % | −103,70 % | −145,00 % | +5,74 % |
| Umsatz · Tatsächlich | 679,71 Mio. | – | 650,65 Mio. | 702,8 Mio. | 702,04 Mio. | 698,3 Mio. | 684,45 Mio. | 702,83 Mio. |
Dividenden und Splits
Keine Dividenden gezahlt.
Aktiensplits
- 1. Feb. 20211:3
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
ENTOEntero Therapeutics, Inc.2,85−5,00 %
GBNHGreenbrook TMS Inc.0,121−40,69 %
HLTHQCue Health Inc.0,00010,00 %
LMDXLumiraDx Limited0,0160,00 %
NSTGNanoString Technologies, Inc.0,1053−37,43 %
NVTAInvitae Corporation0,019−35,59 %
RHERegional Health Properties, Inc.2,7741+3,51 %
RHEPRegional Health Properties, Inc.1,000,00 %
Über das Unternehmen
ModivCare Inc. is a healthcare enterprise leveraging technology to deliver an integrated suite of supportive care solutions. Its services cater to both public and private payers, as well as individual patients. The company organizes its operations into four distinct divisions: Non-Emergency Medical Transportation (NEMT): This segment manages crucial logistics, including contact center operations, network credentialing, and claims processing, alongside coordinating non-emergency medical rides. This service is vital for individuals eligible for Medicaid or Medicare whose mobility challenges or financial constraints would otherwise impede their access to essential healthcare and social support. Personal Care: The Personal Care division dispatches non-medical personal care assistants, home health aides, and skilled nurses to provide comprehensive assistance with daily living activities. These services, predominantly for Medicaid beneficiaries, elderly individuals, and disabled adults, encompass personal hygiene (e.g., bathing, grooming, oral care), dressing, medication reminders, meal preparation and feeding, light housekeeping, and transportation, as well as aid with ambulation. Remote Patient Monitoring (RPM): Through its RPM segment, ModivCare offers advanced technological solutions like personal emergency response systems, continuous vital sign monitoring, medication management tools, and data-driven engagement platforms for patients. Matrix Investment: This segment focuses on delivering care directly within patients' homes or at specific on-site locations. This includes a fleet of mobile health clinics designed to provide community-based care, equipped with sophisticated diagnostic capabilities and a variety of treatment options. ModivCare's clientele spans a wide array, including federal, state, and local government bodies, Managed Care Organizations (MCOs), commercial insurance providers, private citizens, and various health systems. Incorporated in 1996, the company was formerly known as The Providence Service Corporation until its rebranding as ModivCare Inc. in January 2021. Its corporate headquarters are situated in Denver, Colorado.
Führung
- L. Heath SampsonChief Executive Officer, President, Interim President of Modivcare Home & Director
- Barbara K. GutierrezChief Financial Officer
- Jessica KralChief Information Officer
- Henry ToledoChief People Officer
- Chelsey BerstlerExecutive Vice President of Personal Care Services
- Jeff BennettChief Strategy & Innovation Officer
- CEO
- L. Heath Sampson CPA
- Mitarbeitende
- 23.675
- Hauptsitz
- Denver, CO, US
- Sektor
- Healthcare
- Branche
- Medical - Care Facilities
- Börsengang
- 20. Aug. 2003
- Website
- modivcare.com
Nachrichten
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.